Colgate Q1 Earnings & Sales Beat Estimates, Organic Sales Rise 1.4%

25.04.25 18:40 Uhr

Werte in diesem Artikel
Aktien

65,02 EUR -1,42 EUR -2,14%

33,00 JPY 1,00 JPY 3,13%

Indizes

1.498,7 PKT -0,8 PKT -0,05%

5.525,2 PKT 40,4 PKT 0,74%

Colgate-Palmolive Company CL reported first-quarter 2025 results, wherein the bottom and top lines beat the Zacks Consensus Estimate. Earnings improved year over year while sales fell. Results benefited from organic sales growth, robust volume and pricing performance, and gross profit margin expansion. The company is focused on investing in scaling its capabilities in key areas such as digital, data and analytics to enhance competitive advantages and drive profitability.On a Base Business basis (non-GAAP basis), earnings were 91 cents per share, up 6% from the prior-year period. The bottom line surpassed the Zacks Consensus Estimate of 86 cents.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Net sales of $4,911 million inched down 3.1% from the year-ago quarter but surpassed the Zacks Consensus Estimate of $4,855 million. On an organic basis, the company’s sales advanced 1.4%, which includes a 0.4% unfavorable impact from reduced private-label pet volume. Foreign exchange also hurt net sales by 4.4%.A Detailed Picture of CL's Q1 ResultsColgate's organic sales were driven by a 0.1% drop in volume and a 1.5% improvement in pricing. We estimated organic sales growth of 3.4% for the first quarter, with a 2.1% rise in pricing and a 1.3% increase in volume.Colgate-Palmolive Company Price, Consensus and EPS Surprise Colgate-Palmolive Company price-consensus-eps-surprise-chart | Colgate-Palmolive Company QuoteIn the earnings release, management highlighted that the company maintained its leadership in the toothpaste market, holding a 40.9% global market share year to date. In addition, Colgate continued to lead the manual toothbrush market with a 31.9% global market share year to date.The gross profit of $2,987 million decreased from $3,039 million reported in the year-ago quarter. The company’s first-quarter gross profit margin and Base Business gross profit margin expanded 80 basis points (bps), reaching 60.8%. We expected adjusted gross margin expansion of 130 bps to 61.3%.Selling, general and administrative (SG&A) expenses totaled $1,898 million, a decline from $1,916 million in the same quarter of the previous year.The company’s operating profit of $1,076 million jumped from $1,047 million reported in the year-ago quarter. The operating profit margin expanded 120 bps year over year to 21.9%. We expected the operating margin to expand 20 bps to 21.6% for the first quarter.A Peek Into CL’s Segmental DiscussionNorth America’s net sales (20% of total sales) dipped 3.6% year over year on a reported basis and 3% on an organic basis. The sales decline was led by a decrease of 0.7% in pricing and 2.3% in volume.Latin America’s net sales (23% of the total sales) declined 8.7% year over year as a 1.2% pricing gain and a 2.7% increase in volume were more than offset by a 12.7% unfavorable currency impact. On an organic basis, regional sales rose 4%.Europe’s net sales (14% of the total sales) increased 2.5% year over year on a reported basis and 5.4% on an organic basis. Sales growth was driven by a 3% rise in volume and a 2.4% pricing gain, offset by a 2.9% adverse currency impact.The Asia Pacific segment’s net sales (14% of the total sales) fell 5% year over year, reflecting a 3.4% drop in volume, offset by a 0.4% rise in pricing. Regional organic sales also slipped 3.1%.Africa/Eurasia’s net sales (6% of the total sales) dipped 1.5% year over year due to a 2.3% drop in volume and a 3.4% unfavorable currency impact, offset by a 4.1% jump in pricing. Organic sales for the segment advanced 1.8%.Hill’s Pet Nutrition’s net sales (23% of the total sales) improved 1.5% from the year-ago quarter on a reported basis and 2.9% on an organic basis. Results gained from a 3.2% rise in pricing, offset by a 0.3% drop in volume and a 1.4% negative currency impact.CL's Other Financial InformationThis Zacks Rank #3 (Hold) company ended first-quarter 2025 with cash and cash equivalents of $1,112 million and a total debt of $8,269 million. Net cash provided by operating activities was $600 million for the three months ended March 31, 2025. The free cash flow before dividends was $476 million during this time.The company returned $406 million in cash to its shareholders via dividends during first-quarter 2025.Colgate's 2025 OutlookMoving ahead, uncertainty and volatility across the global markets and the impact of tariffs have been challenging. Nevertheless, the company is confident of its strategic initiatives and will accomplish its 2025 financial goals.Based on the existing spot rates and reflecting the anticipated impact of tariffs announced and in effect as of April 24, management presently projects net sales to grow in low single digits, with a low-single-digit adverse impact of foreign exchange. Earlier, Colgate had estimated 2025 net sales to remain relatively flat, with a mid-single-digit negative impact from unfavorable currency exchange rates.The company now predicts an organic sales increase of 2-4% compared with 3-5% growth expected earlier. On a GAAP basis, management envisions both gross profit margin and advertising investment to stay roughly flat as a percentage of sales, and earnings per share (EPS) to increase low single digits.On a non-GAAP (Base Business) basis, the company expects both gross profit margin and advertising to be nearly flat as a percentage of sales, and EPS to grow low single digits. On an adjusted (Base Business) basis, Colgate had earlier forecasted gross profit margin expansion, with advertising investment expected to remain stable or increase slightly in both dollar terms and as a percentage of sales. The company had earlier projected low to mid-single-digit growth in Base Business adjusted EPS for 2025.The company's shares have risen 2.1% in the past three months against the industry’s decline of 1.9%.Here’s How Better-Ranked Stocks FaredUnited Natural Foods UNFI, which is a distributor of natural, organic and specialty food in the United States, currently carries a Zacks Rank #2 (Buy). You can see see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.UNFI delivered a trailing four-quarter earnings surprise of 408.7%, on average. The Zacks Consensus Estimate for UNFI’s current financial-year sales and EPS indicates growth of 1.9% and 485.7%, respectively, from the year-ago numbers. Utz Brands UTZ manufactures salty snacks under popular brands and has a Zacks Rank of 2. UTZ delivered a trailing four-quarter average earnings surprise of 8.8%. The Zacks Consensus Estimate for UTZ’s current financial-year sales and EPS implies growth of 1.4% and 10.4%, respectively, from the year-ago numbers. Nomad Foods NOMD, which manufactures frozen foods, currently carries a Zacks Rank of 2. NOMD delivered a trailing four-quarter earnings surprise of 5%, on average. The Zacks Consensus Estimate for Nomad Foods’ current financial-year EPS indicates growth of 3.1% from the year-ago number. Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Colgate-Palmolive Company (CL): Free Stock Analysis Report United Natural Foods, Inc. (UNFI): Free Stock Analysis Report Nomad Foods Limited (NOMD): Free Stock Analysis Report Utz Brands, Inc. (UTZ): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Omnicom Group und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Omnicom Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Omnicom Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Omnicom Group Inc.

Wer­bung

Analysen zu Omnicom Group Inc.

DatumRatingAnalyst
15.07.2019Omnicom Group Market PerformBMO Capital Markets
17.04.2019Omnicom Group Equal WeightBarclays Capital
16.10.2018Omnicom Group HoldPivotal Research Group
03.04.2018Omnicom Group HoldPivotal Research Group
16.02.2018Omnicom Group OutperformBMO Capital Markets
DatumRatingAnalyst
15.07.2019Omnicom Group Market PerformBMO Capital Markets
16.02.2018Omnicom Group OutperformBMO Capital Markets
18.10.2017Omnicom Group OutperformRBC Capital Markets
18.10.2017Omnicom Group OutperformTelsey Advisory Group
08.03.2017Omnicom Group OutperformRBC Capital Markets
DatumRatingAnalyst
17.04.2019Omnicom Group Equal WeightBarclays Capital
16.10.2018Omnicom Group HoldPivotal Research Group
03.04.2018Omnicom Group HoldPivotal Research Group
16.02.2018Omnicom Group Sector PerformRBC Capital Markets
15.02.2018Omnicom Group HoldPivotal Research Group
DatumRatingAnalyst
13.04.2015Omnicom Group SellPivotal Research Group
08.11.2007Omnicom Group sellBanc of America Sec.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Omnicom Group Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen